Anti-HERV-K Drugs and Vaccines, Possible Therapies against Tumors
The footprint of human endogenous retroviruses (HERV), specifically HERV-K, has been found in malignancies, such as melanoma, teratocarcinoma, osteosarcoma, breast cancer, lymphoma, and ovary and prostate cancers. HERV-K is characterized as the most biologically active HERV due to possession of open...
Main Authors: | Sepideh Hosseiniporgham, Leonardo Antonio Sechi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/4/751 |
Similar Items
-
HERV-K and HERV-H Env Proteins Induce a Humoral Response in Prostate Cancer Patients
by: Maria Antonietta Manca, et al.
Published: (2022-01-01) -
HERV-K Gag RNA and Protein Levels Are Elevated in Malignant Regions of the Prostate in Males with Prostate Cancer
by: Simin D. Rezaei, et al.
Published: (2021-03-01) -
HIV-1 Rev interacts with HERV-K RcREs present in the human genome and promotes export of unspliced HERV-K proviral RNA
by: Laurie R. Gray, et al.
Published: (2019-12-01) -
HERV-K(HML7) Integrations in the Human Genome: Comprehensive Characterization and Comparative Analysis in Non-Human Primates
by: Nicole Grandi, et al.
Published: (2021-05-01) -
Elevated HERV-K Expression in Soft Tissue Sarcoma Is Associated with Worsened Relapse-Free Survival
by: Maria Giebler, et al.
Published: (2018-02-01)